Released on: October 23, 2007, 3:24 am

Press Release Author: Shushmul Maheshwari

Industry:

Press Release Summary: Increase in ailments and diseases is spawning fortunes for
drug-makers! The global protein therapeutics market is poised to grow tremendously
in coming years as these are more efficient than the traditional drugs.

Press Release Body: The frequent discovery of new disease-causing strains has
resulted in increased innovation in drug designing, development, and improved
treatments, and protein therapeutics is one of them. A new report “Global
Protein Therapeutics Market Analysis” by RNCOS, the leading market research
company, provides an in-depth research on the global protein therapeutics market.

‘Therapeutic Proteins’ are actually the proteins engineered in
laboratory for pharmaceutical use. As the treatment is highly effective, its market
is growing by leaps and bounds. The report says that the estimated value of protein
therapeutics market in 2006 was over US$ 57 Billion, a straight growth of around
13.5% from 2005. The report predicts the global protein therapeutics market to grow
at a CAGR of around 12.9% during 2007-2010 and clock about US$ 93 Billion as
revenues.

The report has attributed this concrete growth in the protein therapeutics market to
the high efficiency and ability of this class of drugs to target a particular
disease unlike the traditional pharmaceuticals, increasing frequency of chronic
diseases, ageing population, growing penetration of health insurance, advancements
in the modes of drug delivery, and new indications for protein therapeutics.

The growing market for protein therapeutics is opening other vistas too for growth.
According to the RNCOS report, biogenerics, that is anticipated to emerge as a
billion-dollar industry in near future, will be one of the major opportunity areas
in the protein therapeutics market.

But the success for protein therapeutics market would not come easy. The report says
that certain barriers, like high R&D cost and high failure rate in Phase-3 of
clinical trials, remain an inevitable challenge for the protein therapeutics market
all around the world. Moreover, complex insurance reimbursement procedures and
inconsistent government regulations also threaten the market. However, despite these
inhibitors, the market for protein therapeutics is augured to keep growing at a
double-digit rate through 2010.

The report “Global Protein Therapeutics Market Analysis” gives the most
recent information on the global protein therapeutics market. It evaluates the
market thoroughly and analyzes several protein therapeutics (such as Monoclonal
Antibodies, Erythropoietin, Interferon etc) used for disease control and prevention,
with their market size, areas of application, and future forecast. All the major
geographical markets, like the US, Brazil, Germany, Russia, Japan, and India, for
various protein therapeutics are discussed in the report.

About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. It has a team of
industry experts who analyze data collected from credible sources. They provide
industry insights and analysis that helps corporations to take timely and accurate
business decision in today\'s globally competitive environment.
For more information visit: www.rncos.com/Report/IM557.htm
Current Industry News: http://www.rncos.com/blog


Web Site: http://www.rncos.com

Contact Details: Shushmul Maheshwari
Head of Business Development
29, 1st Floor, Patparganj Industrial Area, Delhi 92
91-11-4214-1229
info@rncos.com